Sinovac Adds Vaccine Capacity by Forming JV

Sinovac Biotech (北京科兴生物制品有限公司) announced a new Joint Venture, Sinovac (Dalian) Vaccine Technology Co., Ltd., that will research, develop and produce human vaccines. Sinovac will contribute its vaccine expertise and capital, while Dalian Jin Gang Group will throw in land use rights, manufacturing facilities and established operating infrastructure. Representatives of Sinovac will fill the major operational posts in the JV. More details... Stock Symbol: (NSDQ: SVA)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.